Anaplastic Large Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • brentuximab vedotin
  • Anaheim, California
  • +18 more
2022-04-01
Apr 1, 2022
S
Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies
Not yet recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • (no location specified)
2022-03-18
Mar 18, 2022
F
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022
M
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
2022-03-11
Mar 11, 2022
C
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
A
Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma
Recruiting
  • T Cell Non-Hodgkin Lymphoma
  • +3 more
  • AUTO4
  • Barcelona, Spain
  • +4 more
2022-02-01
Feb 1, 2022
M
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Active, not recruiting
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
2022-02-03
Feb 3, 2022
N
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
Active, not recruiting
  • Peripheral T-cell Lymphoma NOS
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-02-02
Feb 2, 2022
Z
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
Not yet recruiting
  • Hodgkin Lymphoma
  • +7 more
  • Anti CD30 CAR-T Cell Injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of medicine, Zhejiang Uni
2022-01-12
Jan 12, 2022
W
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
2021-10-28
Oct 28, 2021
T
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
2021-10-04
Oct 4, 2021
C
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
N
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas - 2018
Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
2021-08-30
Aug 30, 2021
S
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
C
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Duarte, California
  • +2 more
2021-08-11
Aug 11, 2021
C
Vinorelbine for Recurrent ALCL-2017
Recruiting
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
2021-07-28
Jul 28, 2021
B
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK- Neoplasms - 2021
Completed
  • Peripheral T Cell Lymphoma
  • +18 more
  • Lake Success, New York
  • +33 more
2021-07-05
Jul 5, 2021
N
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Active, not recruiting
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +16 more
  • Duarte, California
  • +4 more
2021-04-30
Apr 30, 2021
C
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +1 more
2021-04-07
Apr 7, 2021
F
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies - 2018
Terminated
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +32 more
  • indium In 111 anti-CD45 monoclonal antibody BC8
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021
C
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma - 2019
Completed
  • Acute Myeloid Leukemia
  • +7 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2020-11-06
Nov 6, 2020
N
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma - 2015
Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-14
Oct 14, 2020
M
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - 2020
Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
2020-09-28
Sep 28, 2020
C
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) - 2020
Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • New York, New York
  • +2 more
2020-07-15
Jul 15, 2020
N
Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma - 2017
Completed
Has Results
  • Anaplastic Large Cell Lymphoma
  • +12 more
  • Iowa City, Iowa
  • +1 more
2020-04-03
Apr 3, 2020